№ files_lp_3_process_7_102014
File format: docx
Character count: 34274
File size: 69 KB
Accreditation protocol establishing required synoptic data elements and reporting standards for pathologic evaluation of primary uterine sarcoma resection specimens within the CAP Laboratory Accreditation Program.
Year:
2022
Protocol Version:
4.4.0.0
Protocol Posting Date:
March 2022
Required Use Date:
December 2022
Program:
CAP Laboratory Accreditation Program
Issuing Organization:
College of American Pathologists
Committees:
CAP Cancer Committee; CAP Pathology Electronic Reporting Committees
Authors:
Uma G. Krishnamurti, MD, PhD; Barbara A. Crothers, DO
Subject:
Pathologic examination and synoptic reporting of primary uterine sarcoma resection specimens
Tumor Types Covered:
Leiomyosarcoma; Adenosarcoma; Endometrial stromal sarcoma; Undifferentiated uterine/endometrial sarcoma
Excluded Tumor Types:
Carcinoma; Lymphoma
Applicable Procedures:
Total hysterectomy; Supracervical hysterectomy; Radical hysterectomy; Salpingo-oophorectomy; Omentectomy; Peritoneal biopsy; Peritoneal washing
Reporting Standard:
Synoptic reporting format with core and conditional data elements
Staging Standards Referenced:
AJCC-UICC 8; FIGO Cancer Report 2018
Intended Users:
Pathologists and laboratories participating in CAP accreditation
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Document type:
Clinical / Laboratory Form
Organ / Institution:
Pathology Department
Intended user:
Clinicians and laboratory staff
Specimen type:
Uterus and adnexa
Parameters recorded:
Tissue reception, labelling, operative procedure, uterine and cervical dimensions, endometrium, myometrium, leiomyoma, ovaries, fallopian tubes, other macroscopic findings
Organization:
African Energy Commission (AFREC)
Parent Organization:
African Union
Document Type:
Request for Proposals (RFP)
Procurement Number:
AFREC/PRO/08.24
Subject:
Consultancy Service for Conducting an Annual Audit of Project/Programme Support including ISRS 4400
Selection Method:
Quality and Cost Based Selection (70% Technical, 30% Financial)
Issue Date:
15 July 2024
Submission Deadline:
15 August 2024, 1500 hours Algiers time
Submission Method:
Electronic submission in two separate password protected documents (Technical and Financial Proposals)
Contact Email:
[email protected]
Additional Contact:
[email protected]
Required Documents:
Certificate of Incorporation; At least 3 contactable references from the last 5 years; Company profile; CVs of proposed experts; Statements of Availability
Contract Form:
Standard Form of Contract included
Applicable Policy:
African Union procurement and conflict of interest policy
Year:
2020
Institution:
University of Memphis
Course Code:
COMM 4400
Course Type:
University course syllabus
Instructor:
Not specified
Audience:
University students enrolled in COMM 4400
Semester:
Fall 2020
Format:
Online and in-person sessions
Texts:
Tao Te Ching; Philosophical Contemplation by Ran Lahav; From My Land to the Planet by Sebastião Salgado (optional)
Assignments:
Discussion participation, Meditative Journal, Reflective Essay, Readings
Grading Scale:
A-F scale (100-90% = A; 89-80% = B; 79-70% = C; 69-60% = D; 59% and below = F)
Meeting Schedule:
August 18 – November 16, 2020
Policies:
Mask requirement, academic honesty, respect and responsibilities
Protocol version:
6.0
Date:
18 September 2020
Study name:
rEECur
Study design:
International randomised controlled trial
Medical condition:
Recurrent and primary refractory Ewing sarcoma
Intervention:
Chemotherapy
Sponsor:
University of Birmingham
Sponsor protocol number:
RG_13-277
CRCTU number:
SA2015
EudraCT number:
2014-000259-99
ISRCTN reference number:
ISRCTN36453794
Chief Investigator:
Dr Martin McCabe
Coordinating institution:
Cancer Research UK Clinical Trials Unit, University of Birmingham
Geographic scope:
International
Participating regions:
United Kingdom, Germany, Italy, France, Spain, Scandinavia, Australia, New Zealand, Switzerland
Target population:
Patients with recurrent or primary refractory Ewing sarcoma
Regulatory status:
Ethics and regulatory approval required per participating country
Amendment history:
Substantial amendments between 2014 and 2016
Document type:
Clinical trial protocol
Randomisation method:
Centralised online randomisation
Trial phase:
Phase II (Germany-specific limitation noted)
Year:
2021
Region / City:
International
Topic:
Soft tissue sarcoma histopathology
Document Type:
Guide
Organization / Institution:
International Collaboration on Cancer Reporting (ICCR)
Author:
Not specified
Target Audience:
Pathologists, oncologists, medical professionals
Effective Period:
Ongoing
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2019
Region / city:
Not specified
Theme:
Oncology
Document type:
Clinical Protocol
Authors:
Erin Rudzinski, MD; Bruce Pawel, MD; Armita Bahrami, MD; M. John Hicks, MD
Target audience:
Healthcare professionals involved in pediatric oncology
Period of validity:
Not specified
Approval date:
Not specified
Date of modifications:
February 2019
Year of publication:
2025
Receipt of originals:
10/27/2025
Acceptance for publication:
11/27/2025
DOI:
https://doi.org/10.56238/isevjhv4n6-002
Authors:
Fernanda Cristina Galerani Gualtieri Parpinelli; Augustin Malzac; Henrique Lucas Codognoto; Cristina Jardelino de Lima; Guilherme Banck; Diogo Melo Mendo
Type of document:
Narrative literature review
Field:
Oncology; Orthopedic Oncology
Subject:
Multidisciplinary management of osteosarcoma, chondrosarcoma, and Ewing sarcoma
Population focus:
Pediatric and young patients with primary malignant bone tumors
Study period covered:
2015–2025
Databases consulted:
PubMed; Scopus; Cochrane
Therapeutic approaches discussed:
Surgical resection (R0 margins); Neoadjuvant and adjuvant chemotherapy (MAP; VAC/IE); Radiotherapy; Proton therapy; Immune checkpoint inhibitors; CAR-T cell therapy
Molecular aspects:
EWS-FLI1 translocation; IDH1/IDH2 mutations; Circulating tumor DNA (ctDNA)
Imaging modalities:
MRI; CT; PET-CT
Keywords:
Osteosarcoma; Chondrosarcoma; Ewing Sarcoma; Targeted Therapy; EWS-FLI1; Biomarkers; Immunotherapy
Grant Name:
ANZSA 2023 SRG
Year:
2023
Organization:
ANZSA
Related Organization:
ASSG
Document Type:
Grant Application Form
Subject Area:
Sarcoma Research
Application Components:
Applicant Details, Project Description, Budget, Lay Summary, Supporting Documents
Submission Method:
Email submission
Required Attachments:
Curriculum Vitae; Letters of Recommendation or Support (optional)
Project Duration:
12 months
Contact Email:
[email protected]
Year:
2010–2025
Region / City:
Italy
Topic:
Molecular profiling of mesenchymal tumors
Document type:
Consensus paper supplement
Institution:
Italian Sarcoma Group
Audience:
Medical researchers, oncologists, pathologists
Methods:
Literature review, PubMed search, article screening
Number of articles reviewed:
2,699
Number of articles included in final analysis:
146
Additional publications considered:
December 31, 2024 – August 31, 2025
Filters applied:
Full text, clinical trials, guidelines, meta-analyses, observational studies, humans, English language
Search strategy:
Next-generation sequencing, genomic profiling, liquid biopsy, RNAseq, fusion panel, methylation
Reference list selection:
Most relevant articles according to journal guidelines
Systematic review type:
Consensus-based literature review
Screening process:
Title screening, abstract evaluation, full-text evaluation
Year:
2018
Region:
North America
Subject:
Cancer data collection, Soft tissue sarcoma, GIST, Thymoma
Document type:
Guidelines and Q&A
Organization:
NAACCR, AJCC, SEER, CoC
Author:
Not specified
Target audience:
Cancer registrars, clinical coders, oncology data specialists
Effective period:
Cases diagnosed 2018 onward
Date issued:
January 11, 2018
Related resources:
ICD-O 3 Coding Guidelines, FORDS 2016, SEER 2016 Coding Manual, STORE 2018